BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 9422376)

  • 1. Composition and biophysical properties of myelin lipid define the neurological defects in galactocerebroside- and sulfatide-deficient mice.
    Bosio A; Binczek E; Haupt WF; Stoffel W
    J Neurochem; 1998 Jan; 70(1):308-15. PubMed ID: 9422376
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional breakdown of the lipid bilayer of the myelin membrane in central and peripheral nervous system by disrupted galactocerebroside synthesis.
    Bosio A; Binczek E; Stoffel W
    Proc Natl Acad Sci U S A; 1996 Nov; 93(23):13280-5. PubMed ID: 8917582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Galactosphingolipids and axono-glial interaction in myelin of the central nervous system.
    Bosio A; Büssow H; Adam J; Stoffel W
    Cell Tissue Res; 1998 May; 292(2):199-210. PubMed ID: 9560463
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myelination in the absence of galactocerebroside and sulfatide: normal structure with abnormal function and regional instability.
    Coetzee T; Fujita N; Dupree J; Shi R; Blight A; Suzuki K; Suzuki K; Popko B
    Cell; 1996 Jul; 86(2):209-19. PubMed ID: 8706126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myelin abnormalities in mice deficient in galactocerebroside and sulfatide.
    Dupree JL; Coetzee T; Suzuki K; Popko B
    J Neurocytol; 1998 Sep; 27(9):649-59. PubMed ID: 10447239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oligodendrocyte-specific ceramide galactosyltransferase (CGT) expression phenotypically rescues CGT-deficient mice and demonstrates that CGT activity does not limit brain galactosylceramide level.
    Zöller I; Büssow H; Gieselmann V; Eckhardt M
    Glia; 2005 Nov; 52(3):190-8. PubMed ID: 15968630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Demyelination and altered expression of myelin-associated glycoprotein isoforms in the central nervous system of galactolipid-deficient mice.
    Coetzee T; Dupree JL; Popko B
    J Neurosci Res; 1998 Dec; 54(5):613-22. PubMed ID: 9843152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myelination in the absence of UDP-galactose:ceramide galactosyl-transferase and fatty acid 2 -hydroxylase.
    Meixner M; Jungnickel J; Grothe C; Gieselmann V; Eckhardt M
    BMC Neurosci; 2011 Mar; 12():22. PubMed ID: 21366909
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic dissection of myelin galactolipid function.
    Dupree JL; Popko B
    J Neurocytol; 1999; 28(4-5):271-9. PubMed ID: 10739570
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myelin glycolipids and their functions.
    Stoffel W; Bosio A
    Curr Opin Neurobiol; 1997 Oct; 7(5):654-61. PubMed ID: 9384539
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increasing sulfatide synthesis in myelin-forming cells of arylsulfatase A-deficient mice causes demyelination and neurological symptoms reminiscent of human metachromatic leukodystrophy.
    Ramakrishnan H; Hedayati KK; Lüllmann-Rauch R; Wessig C; Fewou SN; Maier H; Goebel HH; Gieselmann V; Eckhardt M
    J Neurosci; 2007 Aug; 27(35):9482-90. PubMed ID: 17728461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cholesterol: a novel regulatory role in myelin formation.
    Saher G; Quintes S; Nave KA
    Neuroscientist; 2011 Feb; 17(1):79-93. PubMed ID: 21343408
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Galactolipids in the formation and function of the myelin sheath.
    Dupree JL; Suzuki K; Popko B
    Microsc Res Tech; 1998 Jun; 41(5):431-40. PubMed ID: 9672425
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The biological role of sulfatides].
    Suchański J; Ugorski M
    Postepy Hig Med Dosw (Online); 2016 May; 70():489-504. PubMed ID: 27180966
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Role of Sulfatides in Axon-Glia Interactions.
    Baba H; Ishibashi T
    Adv Exp Med Biol; 2019; 1190():165-179. PubMed ID: 31760644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Temporal and quantitative expression of the myelin-associated lipids, ethanolamine plasmalogen, galactocerebroside, and sulfatide, in the differentiating CG-4 glial cell line.
    Bichenkov E; Ellingson JS
    Neurochem Res; 1999 Dec; 24(12):1549-56. PubMed ID: 10591405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sulfatide is essential for the maintenance of CNS myelin and axon structure.
    Marcus J; Honigbaum S; Shroff S; Honke K; Rosenbluth J; Dupree JL
    Glia; 2006 Mar; 53(4):372-81. PubMed ID: 16288467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel molecular insights into the critical role of sulfatide in myelin maintenance/function.
    Palavicini JP; Wang C; Chen L; Ahmar S; Higuera JD; Dupree JL; Han X
    J Neurochem; 2016 Oct; 139(1):40-54. PubMed ID: 27417284
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Galactolipids are molecular determinants of myelin development and axo-glial organization.
    Marcus J; Popko B
    Biochim Biophys Acta; 2002 Dec; 1573(3):406-13. PubMed ID: 12417425
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of cyclic AMP on expression of myelin genes in the N20.1 oligodendroglial cell line.
    Studzinski DM; Ramaswamy R; Benjamins JA
    Neurochem Res; 1998 Mar; 23(3):435-41. PubMed ID: 9482258
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.